Despite these recommendations, our data showed that all female BRCA1/2 carriers who underwent breast cancer surveillance used breast ultrasonography (n = 13), while only a small number (n = 4) used breast MRIs. This evidence concerns the gene BRCA1 and breast carcinoma.